- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Hodgkin´s Lymphomas in United States
Total 5083 results
-
Rhizen Pharmaceuticals SACompletedNon Hodgkin LymphomaUnited States, Australia
-
Robert LowskyNational Cancer Institute (NCI)CompletedAcute Myeloid Leukemia | Hodgkin Lymphoma | Chronic Lymphocytic Leukemia | Myelodysplastic Syndrome | B-Cell Non-Hodgkin Lymphoma | Myeloproliferative Neoplasm | T-Cell Non-Hodgkin LymphomaUnited States
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedAggressive B Cell Non-Hodgkin Lymphomas at High Risk for R-CHOP-21-induced NeutropeniaGermany, Italy, Spain
-
GlaxoSmithKlineCompletedNon-Hodgkin's LymphomaUnited States
-
PrECOG, LLC.Genentech, Inc.CompletedFollicular Lymphoma | Non-Hodgkin's Lymphoma Follicular | Non-Hodgkin's Lymphoma, Adult High GradeUnited States
-
CelgeneTerminatedT-cell Non-Hodgkin's LymphomaFrance, United States, Australia, Belgium
-
Astex Pharmaceuticals, Inc.TerminatedProstate Cancer | Non-Hodgkins LymphomaUnited Kingdom, United States
-
Mayo ClinicWithdrawnHodgkin Lymphoma | Stage III Adult Hodgkin Lymphoma | Stage IV Adult Hodgkin Lymphoma | Stage I Adult Hodgkin Lymphoma | Stage II Adult Hodgkin LymphomaUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Adult Hodgkin Lymphoma | Adult Lymphocyte Depletion Hodgkin Lymphoma | Adult Lymphocyte Predominant Hodgkin Lymphoma | Adult Mixed Cellularity Hodgkin Lymphoma | Adult Nodular Sclerosis Hodgkin LymphomaUnited States
-
Dana-Farber Cancer InstituteSanofi; Genzyme, a Sanofi CompanyTerminatedNon Hodgkin Lymphoma | Diffuse Large B Cell Lymphoma | High-grade B-cell LymphomaUnited States
-
Northwestern UniversityEli Lilly and Company; Millennium Pharmaceuticals, Inc.Terminated
-
AIDS Malignancy ConsortiumNational Cancer Institute (NCI); California Institute for Regenerative Medicine...Active, not recruitingHIV Infection | Plasmablastic Lymphoma | Recurrent Adult Hodgkin Lymphoma | Recurrent Adult Non-Hodgkin Lymphoma | Stage III Mantle Cell Lymphoma | Stage IV Mantle Cell Lymphoma | Recurrent Burkitt Lymphoma | Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma | Recurrent Follicular Lymphoma | Stage III Follicular... and other conditionsUnited States
-
The Christie NHS Foundation TrustTerminatedCD19 Positive Non-Hodgkin LymphomaUnited Kingdom
-
John ReneauRecruitingRecurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | Recurrent Adult T-Cell Leukemia/Lymphoma | Refractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | Refractory Adult T-Cell Leukemia/LymphomaUnited States
-
Stanford UniversityTerminatedHematologic Diseases | Leukemia | Hodgkin Lymphoma | Acute-graft-versus-host Disease | Non-Hodgkin Lymphoma (NHL)United States
-
Jennifer AmengualCompletedLymphoma | Multiple Myeloma | Hodgkin Lymphoma | Lymphoid Malignancies | Non-hodgkin LymphomaUnited States
-
Beth ChristianCompletedRecurrent Adult Hodgkin Lymphoma | Adult Lymphocyte Depletion Hodgkin Lymphoma | Adult Lymphocyte Predominant Hodgkin Lymphoma | Adult Mixed Cellularity Hodgkin Lymphoma | Adult Nodular Sclerosis Hodgkin Lymphoma | Adult Nodular Lymphocyte Predominant Hodgkin LymphomaUnited States
-
Washington University School of MedicineCelgene CorporationCompletedHodgkin DiseaseUnited States
-
National Cancer Institute (NCI)CompletedNon Hodgkin's Lymphoma | Hodgkin's DiseaseUnited States
-
Washington University School of MedicineTerminatedLymphoma, Non-Hodgkin | Hodgkin DiseaseUnited States
-
PfizerCompletedLymphoma, B-CellUnited States, Spain, France, Switzerland, United Kingdom, Belgium, Germany
-
Yale UniversityPeter MacCallum Cancer Centre, AustraliaTerminatedMultiple Myeloma | Hodgkin's Lymphoma | Mature T-cell LymphomaUnited States
-
OHSU Knight Cancer InstituteNational Cancer Institute (NCI)CompletedRefractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Recurrent Chronic Lymphocytic Leukemia | Recurrent Indolent Adult Non-Hodgkin LymphomaUnited States
-
Bristol-Myers SquibbCompletedCancer - Solid Tumors and B-Cell Non-Hodgkin's LymphomaUnited States, France, Spain, Germany
-
Hoffmann-La RocheRecruitingNon-Hodgkin's LymphomaBelgium, Australia, Denmark, Spain, Taiwan, France, Italy, United States, Canada, Czechia, New Zealand, Poland, Finland
-
Antengene Biologics LimitedRecruitingAdvanced Solid Tumor | Metastatic Solid Tumor | Mature B-cell Non-Hodgkin LymphomaUnited States, Australia
-
MorphoSys AGCompletedNon-Hodgkin LymphomaUnited States, Belgium, Germany, Hungary, Italy, Poland, Spain
-
Dana-Farber Cancer InstituteBeth Israel Deaconess Medical Center; Brigham and Women's Hospital; MedImmune...CompletedLymphoma | Non-Hodgkin's Lymphoma | Hodgkin's DiseaseUnited States
-
ADC Therapeutics S.A.Withdrawn
-
Ahmed Galal, MDWithdrawnB Cell LymphomasUnited States
-
SecuraBioCompletedIndolent Non-Hodgkin LymphomaKorea, Republic of, Czechia, United States, United Kingdom, Italy, Poland, Russian Federation, Germany
-
Spectrum Pharmaceuticals, IncCompletedLymphoma, B-CellUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Adult Hodgkin Lymphoma | Adult Lymphocyte Depletion Hodgkin Lymphoma | Adult Mixed Cellularity Hodgkin Lymphoma | Adult Nodular Sclerosis Hodgkin LymphomaUnited States
-
Merck Sharp & Dohme LLCActive, not recruitingHodgkin's Lymphoma | Primary Mediastinal Large B-cell Lymphoma (PMBCL)Canada, United States, Brazil, Czechia, France, Italy, Poland, Russian Federation, South Africa, Turkey, Ukraine
-
UNC Lineberger Comprehensive Cancer CenterNational Heart, Lung, and Blood Institute (NHLBI)Active, not recruitingNeoplasms | Immune System Diseases | Neoplasms by Histologic Type | Lymphoma | Lymphoproliferative Disorders | Lymphatic Diseases | Immunoproliferative Disorders | Lymphoma, Non-Hodgkin | Hodgkin DiseaseUnited States
-
Hoffmann-La RocheCompletedB-cell Non-Hodgkin LymphomaUnited States, Spain, Korea, Republic of, France, Austria, Poland
-
Iksuda Therapeutics Ltd.RecruitingFollicular Lymphoma | B-cell Lymphoma | Mantle Cell Lymphoma | Diffuse Large B Cell Lymphoma | B-cell Non-Hodgkin LymphomaAustralia, Canada, United States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedLymphomaUnited States, Canada
-
BeiGeneActive, not recruitingRelapsed/Refractory Follicular Non-Hodgkin LymphomaKorea, Republic of, New Zealand, United States, China, Taiwan, Spain, Italy, Australia, Canada, United Kingdom, Belarus, Bulgaria, Czechia, France, Germany, Poland, Russian Federation
-
Artiva Biotherapeutics, Inc.RecruitingNon Hodgkin LymphomaUnited States
-
Robert LowskyTerminatedLymphoma, Non-Hodgkin | Hodgkin DiseaseUnited States
-
M.D. Anderson Cancer CenterNovartisCompleted
-
University of Wisconsin, MadisonGenentech, Inc.Terminated
-
Sanjiv Sam GambhirWithdrawnNon-Hodgkin's LymphomaUnited States
-
M.D. Anderson Cancer CenterGenentech, Inc.Terminated
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedLymphomaUnited States
-
InterMuneTerminatedNon-Hodgkin's LymphomaUnited States
-
Eisai Inc.CompletedLymphoma, B-CellUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Splenic Marginal Zone Lymphoma | Anaplastic Large Cell Lymphoma | Recurrent Adult Hodgkin Lymphoma | Recurrent Small Lymphocytic Lymphoma | Recurrent... and other conditionsUnited States
-
National Cancer Institute (NCI)TerminatedAcute Lymphoblastic Leukemia | Acute Myelogenous Leukemia | Chronic Myelogenous Leukemia | Non-Hodgkins Lymphoma | Hodgkins LymphomaUnited States